Shanghai Baoju
Retatrutide
Finnrick tested 5 samples of Retatrutide (GLP-1, GIP, and GCGR agonist) from Shanghai Baoju between 3 Oct 2025 and 16 Dec 2025. Test scores average below 4 or some scores below 3, and at least 2 tests, warrant a tentative Finnrick Rating of E (Bad).
Finnrick Rating™
Tentative Rating
Shanghai Baoju
Retatrutide
Tested 5 Samples
Last test 16 Dec 2025
Take Action
Researcher
Request Full Data Access to the Finnrick database of peptide tests.
Free peptide testing
Mail in a sample (US only) to get confidence for the specific vials you have, and contribute to identifying unsafe supply chains, so other people can avoid risky and costly mistakes.
Other Retatrutide tests from top-rated vendors:
All Retatrutide tests from Shanghai Baoju
Samples are tested in commercial labs
Tests Count
5
Scores
AVGMINMAX
Last
16 Dec 2025
First
3 Oct 2025
| Quantity | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|
| Test Date | Certificate | Test Score | Label | Tested | Difference | Purity | Batch ID | Container | Tested At | Sent By |
| 16 Dec 2025 | View | 10mg | ⚠️ Sample does not contain Retatrutide | 11/2025 L | White Label / Silver Crimp / Clear Blue Cap | Lab G | Public | |||
| 16 Dec 2025 | View | 20mg | 19.6mg | -2.0% | 99.70% | 11/2025 L | White Label / Silver Crimp / Violet Cap | Lab G | Public | |
| 25 Nov 2025 | View | 20mg | 22.5mg | +12.5% | 99.95% | (no batch ID) | No Label / Silver Crimp / Clear Pink Cap | Lab E | Public | |
| 14 Nov 2025 | View | 5mg | 5.1mg | +2.0% | 99.80% | (no batch ID) | No Label / Silver Crimp / Clear Pink Cap | Lab G | Public | |
| 3 Oct 2025 | View | 5mg | 4.64mg | -7.2% | 99.93% | (no batch ID) | White Label / Silver Crimp / Violet Cap | Lab E | Public | |